Literature DB >> 17991792

Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation.

Ronald L Sorkness1, Eugene R Bleecker, William W Busse, William J Calhoun, Mario Castro, Kian Fan Chung, Douglas Curran-Everett, Serpil C Erzurum, Benjamin M Gaston, Elliot Israel, Nizar N Jarjour, Wendy C Moore, Stephen P Peters, W Gerald Teague, Sally E Wenzel.   

Abstract

Five to ten percent of asthma cases are poorly controlled chronically and refractory to treatment, and these severe cases account for disproportionate asthma-associated morbidity, mortality, and health care utilization. While persons with severe asthma tend to have more airway obstruction, it is not known whether they represent the severe tail of a unimodal asthma population, or a severe asthma phenotype. We hypothesized that severe asthma has a characteristic physiology of airway obstruction, and we evaluated spirometry, lung volumes, and reversibility during a stable interval in 287 severe and 382 nonsevere asthma subjects from the National Heart, Lung, and Blood Institute Severe Asthma Research Program. We partitioned airway obstruction into components of air trapping [indicated by forced vital capacity (FVC)] and airflow limitation [indicated by forced expiratory volume in 1 s (FEV(1))/FVC]. Severe asthma had prominent air trapping, evident as reduced FVC over the entire range of FEV(1)/FVC. This pattern was confirmed with measures of residual lung volume/total lung capacity (TLC) in a subgroup. In contrast, nonsevere asthma did not exhibit prominent air trapping, even at FEV(1)/FVC <75% predicted. Air trapping also was associated with increases in TLC and functional reserve capacity. After maximal bronchodilation, FEV(1) reversed similarly from baseline in severe and nonsevere asthma, but the severe asthma classification was an independent predictor of residual reduction in FEV(1) after maximal bronchodilation. An increase in FVC accounted for most of the reversal of FEV(1) when baseline FEV(1) was <60% predicted. We conclude that air trapping is a characteristic feature of the severe asthma population, suggesting that there is a pathological process associated with severe asthma that makes airways more vulnerable to this component.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17991792     DOI: 10.1152/japplphysiol.00329.2007

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  89 in total

1.  Lung development and the host response to influenza A virus are altered by different doses of neonatal oxygen in mice.

Authors:  Bradley W Buczynski; Min Yee; B Paige Lawrence; Michael A O'Reilly
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-03-09       Impact factor: 5.464

2.  Platelet activation, P-selectin, and eosinophil β1-integrin activation in asthma.

Authors:  Mats W Johansson; Shih-Tsung Han; Kristin A Gunderson; William W Busse; Nizar N Jarjour; Deane F Mosher
Journal:  Am J Respir Crit Care Med       Date:  2012-01-06       Impact factor: 21.405

3.  Bronchodilation response to deep inspirations in asthma is dependent on airway distensibility and air trapping.

Authors:  George Pyrgos; Nicola Scichilone; Alkis Togias; Robert H Brown
Journal:  J Appl Physiol (1985)       Date:  2010-11-11

4.  Redistribution of inhaled hyperpolarized 3He gas during breath-hold differs by asthma severity.

Authors:  Andrew D Hahn; Robert V Cadman; Ronald L Sorkness; Nizar N Jarjour; Scott K Nagle; Sean B Fain
Journal:  J Appl Physiol (1985)       Date:  2015-12-03

5.  Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma.

Authors:  Michael E Wechsler; Michel Laviolette; Adalberto S Rubin; Jussara Fiterman; Jose R Lapa e Silva; Pallav L Shah; Elie Fiss; Ronald Olivenstein; Neil C Thomson; Robert M Niven; Ian D Pavord; Michael Simoff; Jeff B Hales; Charlene McEvoy; Dirk-Jan Slebos; Mark Holmes; Martin J Phillips; Serpil C Erzurum; Nicola A Hanania; Kaharu Sumino; Monica Kraft; Gerard Cox; Daniel H Sterman; Kyle Hogarth; Joel N Kline; Adel H Mansur; Brian E Louie; William M Leeds; Richard G Barbers; John H M Austin; Narinder S Shargill; John Quiring; Brian Armstrong; Mario Castro
Journal:  J Allergy Clin Immunol       Date:  2013-08-30       Impact factor: 10.793

6.  Registration-based assessment of regional lung function via volumetric CT images of normal subjects vs. severe asthmatics.

Authors:  Sanghun Choi; Eric A Hoffman; Sally E Wenzel; Merryn H Tawhai; Youbing Yin; Mario Castro; Ching-Long Lin
Journal:  J Appl Physiol (1985)       Date:  2013-06-06

7.  Markers of vascular perturbation correlate with airway structural change in asthma.

Authors:  Mats W Johansson; Stanley J Kruger; Mark L Schiebler; Michael D Evans; Ronald L Sorkness; Loren C Denlinger; William W Busse; Nizar N Jarjour; Robert R Montgomery; Deane F Mosher; Sean B Fain
Journal:  Am J Respir Crit Care Med       Date:  2013-07-15       Impact factor: 21.405

8.  Bronchodilator Dose Responsiveness in Children and Adolescents: Clinical Features and Association with Future Asthma Exacerbations.

Authors:  Jocelyn R Grunwell; Khristopher M Nguyen; Alice C Bruce; Anne M Fitzpatrick
Journal:  J Allergy Clin Immunol Pract       Date:  2019-10-12

9.  Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction.

Authors:  Eleanor M Dunican; Brett M Elicker; David S Gierada; Scott K Nagle; Mark L Schiebler; John D Newell; Wilfred W Raymond; Marrah E Lachowicz-Scroggins; Selena Di Maio; Eric A Hoffman; Mario Castro; Sean B Fain; Nizar N Jarjour; Elliot Israel; Bruce D Levy; Serpil C Erzurum; Sally E Wenzel; Deborah A Meyers; Eugene R Bleecker; Brenda R Phillips; David T Mauger; Erin D Gordon; Prescott G Woodruff; Michael C Peters; John V Fahy
Journal:  J Clin Invest       Date:  2018-02-05       Impact factor: 14.808

10.  Mesenchymal stromal cells mediate Aspergillus hyphal extract-induced allergic airway inflammation by inhibition of the Th17 signaling pathway.

Authors:  Melissa J Lathrop; Elice M Brooks; Nick R Bonenfant; Dino Sokocevic; Zachary D Borg; Meagan Goodwin; Roberto Loi; Fernanda Cruz; Chad W Dunaway; Chad Steele; Daniel J Weiss
Journal:  Stem Cells Transl Med       Date:  2014-01-16       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.